Jiangsu Zhongdan

Jiangsu Zhongdan Group is a large-scale Chinese enterprise specializing in the research, development, and manufacturing of fine chemicals, pharmaceuticals, and new materials. The company operates a significant pharmaceutical division, Jiangsu Zhongdan Pharmaceutical, which focuses on the production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Their pharmaceutical portfolio is particularly strong in non-steroidal anti-inflammatory drugs (NSAIDs) and various chemical intermediates used in drug synthesis. With extensive manufacturing facilities, the group serves as a key supplier to the global healthcare and chemical industries. Zhongdan Group is recognized for its integrated production chain, moving from basic chemical raw materials to high-value pharmaceutical products.